Home / Posts Tagged "pharmaceutical" (Page 2)

The Indian pharmaceutical sector is strategically poised to capitalize on the recent healthcare initiatives introduced by President Donald Trump, aimed at enhancing the affordability and accessibility of medical treatments in the United States. This development presents significant opportunities for Indian drug manufacturers to expand their

READ MORE

Commitment to stringent European standards reinforces Venus Remedies’ leadership in antibiotics and oncology manufacturing while positioning the company for continued growth in global markets  Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a premier player in the global pharmaceutical industry, has announced the successful renewal of its

READ MORE

The Skill Development Centre aims to enhance the skills of community members Anyone in the community can enrol and gain relevant skills for employability The Skill Development Centre will train 600-720 candidates annually The Dr. Vijay Kumar Datla Foundation, the CSR arm of Biological E. Limited, in collaboration

READ MORE

A 3-Day Exhibition and Summit at Bombay Exhibition Centre, Supported by, Indian Drug Manufacturers’ Association (IDMA), Federation of Pharmaceutical and Allied Products Merchant Exports (FPME), Federation of Pharma Entrepreneurs (FOPE) and Leading Industry Associations The event will bring together 225+ exhibitors and showcase 12000+

READ MORE

Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient

READ MORE

Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone in workforce development by

READ MORE

Mumbai, December 17, 2024 – Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine

READ MORE

Launches Single-Use Assemblies & ASTC UV-Shield Tubing for Indian customers Freudenberg, a worldwide technology business based in Germany, will attend CPhI & PMEC India 2024 on November 26-28. Freudenberg, a trusted supplier of biopharmaceutical devices, systems, high-performance sealing, and filtering solutions, services to pharmaceutical and

READ MORE

Granules' Ambitious Climate Targets Span Near-Term, Long-Term, and Net-Zero Goals, Aligned with the 1.5°C Pathway Granules India Limited, a leading global pharmaceutical company, has received validation and approval from the Science Based Targets initiative (SBTi) for its near-term, long-term, and net-zero goals. These targets, aligned with the

READ MORE

The report provides perspectives on the Indian market, key trends that are shaping its future and the role Global Pharma companies have been played in unlocking quality healthcare. India remains a hub of innovation and a global economic bright spot. Proactive efforts by the

READ MORE